Detalhe da pesquisa
1.
Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.
Genes Chromosomes Cancer
; 55(12): 915-924, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27328445
2.
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Am J Hematol
; 90(5): E80-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653205
3.
An immunomodulatory activity of micafungin in preclinical aspergillosis.
J Antimicrob Chemother
; 69(4): 1065-74, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265229
4.
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.
Leukemia
; 37(8): 1671-1685, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386079
5.
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
Br J Haematol
; 156(2): 205-12, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22082314
6.
Implication of MAPK1/MAPK3 signalling pathway in t(8;9)(p22;24)/PCM1-JAK2 myelodysplastic/myeloproliferative neoplasms.
Br J Haematol
; 162(4): 563-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23701125
7.
MSH2 role in BRCA1-driven tumorigenesis: A preliminary study in yeast and in human tumors from BRCA1-VUS carriers.
Eur J Med Genet
; 58(10): 531-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26381082